This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $1,224.36 for the supply of Repatha 140 mg/ml SureClick medication. The contract is a firm fixed-price agreement and has an ultimate completion date of November 29, 2023. The award was made by the Defense Logistics Agency (DLA), a defense agency, and is not designated as a set-aside contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,100.38 firm fixed-price delivery order is for the supply of Repatha 140 mg/mL SureClick medication. The contract has a completion date of May 3, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award, valued at $1,735.70, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Repatha 140 mg/mL SureClick medication. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 29, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation for this award. The contract is associated with a larger Indefinite Delivery...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to deliver Repatha 140 mg/ml SureClick medication. The contract, valued at $1,355.76, is a Delivery Order awarded by the Defense Logistics Agency (DLA) and has an ultimate completion date of October 28, 2024. The contract type is Firm Fixed Price, and there is no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite...
This federal contract award, valued at $43,022.66, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and covers the supply of Repatha 140 mg/ml SureClick medication. The award appears to be part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,082.84, is for the delivery of Repatha 140 mg/mL SureClick medication. It is a firm-fixed-price delivery order contract with an ultimate completion date of April 14, 2025. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a larger $999,999,999...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,851.35 firm fixed-price delivery order contract is for the supply of Repatha 140 mg/ml SureClick medication. The contract has an ultimate completion date of January 22, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award, valued at $2,082.84, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of Repatha, a 140 mg/mL SureClick injection, with an ultimate completion date of April 17, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is a delivery order from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,351.95, is for the supply of Repatha 140 mg/ml SureClick injections. It is a firm fixed-price contract with a performance period through May 15, 2025. The contract is not set aside and is awarded under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract, valued at up to $2,164.48, is for the delivery of Repatha 140 mg/ml SureClick medication. The contract is a Delivery Order with a Firm Fixed Price pricing type, with an ultimate completion date of May 3, 2024. The award is not associated with a set-aside...